Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DTC CHILL HAS BEEN REMOVED
FREDERICK, Md., March 20, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that the Depository Trust Company has determined to end the deposit transaction restriction (the Deposit Chill) it had previously placed on shares of BioElectronics.
TheCompanysaid it was notified of the Depository Trust Company's decision in a letter via email to James D. Pierce, Esq. of Sugarland, Texas has represented the corporation in this matter. The letter from DTC counsel Donald Maj saidthat the DTC has "resumed accepting deposits of the Issue for deposits and book entry transfer services."
"We are pleased that the DTC has decided to remedy this situation which has been an inconvenience and burden on our shareholders," said Richard Staelin, Chairman of the Board of BioElectronics Corporation and the Edward and Rose Donnell Professor of Business Administration at The Fuqua School of Business, Duke University.
"We expect that our shareholders will soon see an improvement in the trading environment as the news of this action is acted upon by the brokerage community."
HUGE NEWS BIEL:
FREDERICK, Md., March 20, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that the Depository Trust Company has determined to end the deposit transaction restriction (the Deposit Chill) it had previously placed on shares of BioElectronics.
TheCompanysaid it was notified of the Depository Trust Company's decision in a letter via email to James D. Pierce, Esq. of Sugarland, Texas has represented the corporation in this matter. The letter from DTC counsel Donald Maj saidthat the DTC has "resumed accepting deposits of the Issue for deposits and book entry transfer services."
"We are pleased that the DTC has decided to remedy this situation which has been an inconvenience and burden on our shareholders," said Richard Staelin, Chairman of the Board of BioElectronics Corporation and the Edward and Rose Donnell Professor of Business Administration at The Fuqua School of Business, Duke University.
"We expect that our shareholders will soon see an improvement in the trading environment as the news of this action is acted upon by the brokerage community."
FREDERICK, Md., March 20, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that the Depository Trust Company has determined to end the deposit transaction restriction (the Deposit Chill) it had previously placed on shares of BioElectronics.
TheCompanysaid it was notified of the Depository Trust Company's decision in a letter via email to James D. Pierce, Esq. of Sugarland, Texas has represented the corporation in this matter. The letter from DTC counsel Donald Maj saidthat the DTC has "resumed accepting deposits of the Issue for deposits and book entry transfer services."
"We are pleased that the DTC has decided to remedy this situation which has been an inconvenience and burden on our shareholders," said Richard Staelin, Chairman of the Board of BioElectronics Corporation and the Edward and Rose Donnell Professor of Business Administration at The Fuqua School of Business, Duke University.
"We expect that our shareholders will soon see an improvement in the trading environment as the news of this action is acted upon by the brokerage community."
BIEL.....HUGE NEWS POSTED $$$$
This stock will break over a penny on the right news. We all know that news is coming.
$$ BIEL $$ SETTING UP NICELY FOR NEXT WEEK.
$$ BIEL $$ SETTING UP NICELY FOR NEXT WEEK.
I expect a 510k submission announce next week. BIEL will break a penny with that news instead of this fluff PRs we've been getting
Consolidating nicely at these levels. I expect another pop sometime today
$BIEL~~CHART~ GOLDEN CROSS HAPPENING NOW!! VERY BULLISH!
http://stockcharts.com/h-sc/ui?s=biel
Report TOS
Very few shares in the way to a penny
Nice buys coming in today
Awards show tomorrow night. Another PR coming tomorrow or Friday.
$$ BIEL$$ GOLDEN CROSS FORMING
GOLDEN CROSS COMING ON BIEL $$$$$
BIEL MORE FDA NEWS COMING, PENNYLAND EASY, 2009 LEVELS COMING
BioElectronics researchers and clinicians support US FDA’s position to reclassify shortwave medical devices to Class II
Maryland
Saturday, March 01, 2014, 13:00 Hrs [IST]
Medical device researchers and clinicians at BioElectronics Corp. are optimistically supportive of the US Food and Drug Administration (FDA)’s decision last week to reclassify and rename electronic shortwave diathermy for many other uses, a decision that may improve access to safe, clinically tested medical devices that serve as alternatives to risky pain medications.
Officials with Frederick, Maryland-based BioElectronics Corp., makers of inexpensive, disposable medication-free anti-inflammatory medical devices, said its extensive clinical and laboratory data underscore the FDA’s new direction regarding shortwave medical devices.
“We are enthusiastic about the FDA’s new decision as it galvanizes the international medical community’s scientific view of these safe and effective medical devices,” said Lawrence L Michaelis MD, emeritus professor of Surgery, Feinberg School of Medicine of Northwestern University and head of the Medical Advisory Board of BioElectronics Corp. “These effective, low-cost products are available over-the-counter all over the rest of the world. Clinical data from many studies have proven the efficacy of these alternative therapies and hundreds of thousands of patients outside of the US have benefitted from them – without any known adverse side effects.”
Dr Michaelis said the company will be submitting data from a number of clinical and laboratory studies to the FDA as the company seeks new 510K applications for reclassified and renamed medical devices. “Patients who suffer from chronic or acute musculoskeletal pain deserve access to more than just high risk pain medications,” he said. “We are very pleased with the FDA’s new approach to these devices.”
BioElectronics Corporation is a leader in biophysics and the maker of an industry leading family of disposable, drug-free, pain treatment devices: ActiPatch Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx Devices for chronic and post-operative wound care; HealFast Therapy and the Allay Menstrual Pain Therapy.
BioElectronics researchers and clinicians support US FDA’s position to reclassify shortwave medical devices to Class II
Maryland
Saturday, March 01, 2014, 13:00 Hrs [IST]
Medical device researchers and clinicians at BioElectronics Corp. are optimistically supportive of the US Food and Drug Administration (FDA)’s decision last week to reclassify and rename electronic shortwave diathermy for many other uses, a decision that may improve access to safe, clinically tested medical devices that serve as alternatives to risky pain medications.
Officials with Frederick, Maryland-based BioElectronics Corp., makers of inexpensive, disposable medication-free anti-inflammatory medical devices, said its extensive clinical and laboratory data underscore the FDA’s new direction regarding shortwave medical devices.
“We are enthusiastic about the FDA’s new decision as it galvanizes the international medical community’s scientific view of these safe and effective medical devices,” said Lawrence L Michaelis MD, emeritus professor of Surgery, Feinberg School of Medicine of Northwestern University and head of the Medical Advisory Board of BioElectronics Corp. “These effective, low-cost products are available over-the-counter all over the rest of the world. Clinical data from many studies have proven the efficacy of these alternative therapies and hundreds of thousands of patients outside of the US have benefitted from them – without any known adverse side effects.”
Dr Michaelis said the company will be submitting data from a number of clinical and laboratory studies to the FDA as the company seeks new 510K applications for reclassified and renamed medical devices. “Patients who suffer from chronic or acute musculoskeletal pain deserve access to more than just high risk pain medications,” he said. “We are very pleased with the FDA’s new approach to these devices.”
BioElectronics Corporation is a leader in biophysics and the maker of an industry leading family of disposable, drug-free, pain treatment devices: ActiPatch Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx Devices for chronic and post-operative wound care; HealFast Therapy and the Allay Menstrual Pain Therapy.
NICE BUYS COMING IN, MAY ACTUALLY FINISH GREEN TODAY
PATIENCE WILL BE REWARDED, WE GOING BACK TO 2009 LEVELS, ALL THE LONGS KNOW THAT
down 15% is not brutal, we will be in the spotlight end of week with the awards banquet
end of day buying should set this up nicely for tomorrow, needed a profit day
---BIEL BOUNCE ALERT---
15% drop today means 35% up tomorrow
BIEL GOING TO A PENNY
BIEL GOLDEN CROSS COMING
$$BIEL$$ GET IN NOW BEFORE FDA APPROVAL$$$$
$$BIEL$$ GET IN NOW BEFORE FDA APPROVAL $$$$$$
Everyone wants FDA news but they are educating people just like they said they would in the update to investors, Once the FDA PR's come out we will see over 100% gains in a day
MM's are holding it down. Should shoot back up
L2 is thin to 67
Expect PR tomorrow. Every 3 days. : )
BIEL about to break out. Super thin to .01
BIEL making EOD run. +.01 End of week.
BIEL making EOD run. + .01 end of week.
I believe we could see another little run at close.
Last 30 minutes have been all buys
Why sell now? Makes no sense.
$$BIEL$$ chart looks sweet. Start loading now, more FDA news coming and a run to the pennies.